Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats

Neuroscience Letters

Volumn 332, Issue 2, 2002, Pages 83-86

  Callaway, Narriman Lee ^a   Riha, Penny D ^a   Wrubel, Kathryn M ^a   McCollum, David ^a   Gonzalez Lima, F ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cytochrome c oxidase; Electron transport chain; Holeboard; Memory consolidation; Mitochondrial respiration; Neurodegenerative diseases; Oxygen consumption; Sodium azide

Indexed keywords

CYTOCHROME C OXIDASE; ENZYME INHIBITOR; METHYLENE BLUE; SODIUM AZIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CELL RESPIRATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG TARGETING; ELECTRON TRANSPORT; ENZYME INHIBITION; MALE; MAZE TEST; MEMORY CONSOLIDATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; CUES; ELECTRON TRANSPORT COMPLEX IV; ENZYME INHIBITORS; INJECTIONS, INTRAPERITONEAL; LEARNING; MALE; MEMORY; METHYLENE BLUE; ODORS; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SODIUM AZIDE; SPACE PERCEPTION;

EID: 0037206645     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00827-3     Document Type: Article

References (20)

1. Beal M.F., Hyman B.T., Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16:1993;125-131.
2. Bennett M.C., Mlady G.W., Fleshner M., Rose G.M. Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity. Proc. Natl. Acad. Sci. USA. 93:1996;1330-1334.
3. Bennett M.C., Rose G.M. Chronic sodium azide treatment impairs learning of the Morris water maze task. Behav. Neural Biol. 58:1992;72-75.
4. Berndt J.D., Callaway N.L., Gonzalez-Lima F. Effects of chronic sodium azide on brain and muscle cytochrome oxidase activity: a potential model to investigate environmental contributions to neurodegenerative diseases. J. Toxicol. Environ. Health Part A. 63:2001;67-77.
5. Bowling A.C., Beal M.F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56:1995;1151-1171.
6. Cada A., Gonzalez-Lima F., Rose G.M., Bennett M.C. Regional brain effects of sodium azide treatment on cytochrome oxidase activity: a quantitative histochemical study. Metab. Brain Dis. 10:1995;303-319.
7. DiSanto A.R., Wagner J.G. Pharmacokinetics of highly ionized drugs I: methylene blue - whole blood, urine, and tissue assays. J. Pharm. Sci. 61:1972;598-602.
8. Gonzalez-Lima F., Cytochrome Oxidase in Neuronal Metabolism and Alzheimer's Disease. 1998;Plenum, New York.
9. Gonzalez-Lima F., Valla J., Matos-Collazo S. Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients. Brain Res. 752:1997;117-126.
10. Harvey S.C. Antiseptics and disinfectants: fungicides, ectoparasiticides. Goodman L.S., Gilman A., The Pharmacological Basis of Therapeutics. 5th Edition:1970;1003-1004 MacMillan, New York.
11. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779.
12. Küpfer A., Aeschlimann C., Wermuth B., Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet. 343:1994;763-764.
13. Maldonado-Irizarry C.S., Kelley A.E. Excitatory amino acid receptors within nucleus accumbens subregions differentially mediate spatial learning in the rat. Behav. Pharmacol. 6:1995;527-539.
14. Martinez J.L. Jr., Jensen R.A., Vasquez B.J., McGuinness T., McGaugh J.L. Methylene blue alters retention of inhibitory avoidance responses. Physiol. Psychol. 6:1978;387-390.
15. Peter C., Hongwan D., Küpfer A., Lauterburg B.H. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur. J. Clin. Pharmacol. 56:2000;247-250.
16. Salaris S.C., Barbs C.F., Voorhees W.D. III. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. Biochem. Pharmacol. 42:1991;499-506.
17. Valla J., Berndt J.D., Gonzalez-Lima F. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J. Neurosci. 21:2001;4923-4930.
18. Visarius T.M., Stucki J.W., Lauterburg B.H. Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett. 412:1997;157-160.
19. Wada H., Woo M., Nishio H., Nagaki S., Yanagawa H., Imamura A., Yokoyama S., Ohbayashi C., Matsuo M., Itoh H., Nakamura H. Vascular involvement in benign infantile mitochondrial myopathy caused by reversible cytochrome c oxidase deficiency. Brain Dev. 18:1996;263-268.
20. Wischik C.M., Edwards P.C., Lai R.Y.K., Roth M., Harrington C.R. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc. Natl. Acad. Sci. USA. 93:1996;11213-11218.